Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-26 @ 3:03 AM
NCT ID:
NCT02038920
Group ID:
EG005
Title:
Open-Label: Vedolizumab 300 mg
Description:
Vedolizumab 300 mg, IV infusion, once at Weeks 0, 2 and 6 and then every 8 weeks thereafter up to Week 94 as a maximum duration in open-label phase.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
70
Serious Number At Risk:
134
Other Number Affected:
113
Other Number At Risk:
134
Study:
NCT02038920
Results Section:
NCT02038920
Adverse Events Module:
NCT02038920